The Singapore Infectious Disease Therapeutics Market Size is anticipated to exceed USD 245.5 Million by 2033, growing at a CAGR of 4.95% from 2023 to 2033. The increasing incidence of infectious ailments, increasing expenditure on disease treatment, and product launches are driving the growth of the infectious disease therapeutics market in the Singapore.